108 related articles for article (PubMed ID: 3659048)
21. Future directions in QOL research.
Mandrekar S; Dueck A
Curr Probl Cancer; 2005; 29(6):343-51. PubMed ID: 16311136
[No Abstract] [Full Text] [Related]
22. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
23. Optimal timing for QOL assessments.
Burger K; Mandrekar S
Curr Probl Cancer; 2005; 29(6):278-84. PubMed ID: 16311129
[No Abstract] [Full Text] [Related]
24. Assessment of quality of life in patients with prostate cancer.
Fosså SD; Aass N; Opjordsmoen S
Semin Oncol; 1994 Oct; 21(5):657-61. PubMed ID: 7524156
[No Abstract] [Full Text] [Related]
25. Quality of life after therapy for localized prostate cancer.
Penson DF
Cancer J; 2007; 13(5):318-26. PubMed ID: 17921731
[TBL] [Abstract][Full Text] [Related]
26. Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer.
Garnick MB; Fair WR; Bostwick D; Debruyne F; Fourcroy J; Grignon D; Porterfield H; Sufrin G; Thrasher B; Hart C
Mol Urol; 2000; 4(3):89-92. PubMed ID: 11184767
[No Abstract] [Full Text] [Related]
27. Toxicity and health-related quality-of-life assessment in prostate radiotherapy.
Rodrigues G; Lock M; D'Souza D
Can J Urol; 2007 Aug; 14(4):3608-15. PubMed ID: 17784980
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
McNaughton-Collins M; Walker-Corkery E; Barry MJ
J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
[TBL] [Abstract][Full Text] [Related]
29. Re: Life after radical prostatectomy: a longitudinal study.
Loren AW; Bennett I; Cronholm P; Ochroch A; Taichman D
J Urol; 2002 Jul; 168(1):203-4; author reply 204. PubMed ID: 12050540
[No Abstract] [Full Text] [Related]
30. Quality of life and prostate cancer treatment: decision-making and rehabilitative support.
Ritvo PG
Can J Oncol; 1994 Nov; 4 Suppl 1():43-5; discussion 46. PubMed ID: 8853489
[No Abstract] [Full Text] [Related]
31. [Significance and problems of quality-of-life assessment in clinical trials].
Shimozuma K; Sonoo H
Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):183-8. PubMed ID: 9987517
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life: a measure of process and outcome.
Nguyen LL; Henry AJ
Vasc Med; 2010 Jun; 15(3):233-4. PubMed ID: 20332177
[No Abstract] [Full Text] [Related]
33. Clinical trials. Referral resource. Clinical trials assessing quality of life.
Cheson BD; McCabe MS; Phillips PH
Oncology (Williston Park); 1995 Nov; 9(11):1171-4, 1176, 1178. PubMed ID: 8703685
[No Abstract] [Full Text] [Related]
34. The impact of quality of life measurements on the patient.
Chauhan C; Eppard W
Curr Probl Cancer; 2005; 29(6):332-42. PubMed ID: 16311135
[No Abstract] [Full Text] [Related]
35. Editorial comment.
Penson DF
J Urol; 2010 Jun; 183(6):2191-2. PubMed ID: 20399467
[No Abstract] [Full Text] [Related]
36. Quality of life after treatment for prostate cancer: no difference between surgery and radiotherapy?
Vordermark D; Koelbl O
J Clin Oncol; 2003 Dec; 21(24):4655; author reply 4655-6. PubMed ID: 14673059
[No Abstract] [Full Text] [Related]
37. Nursing intervention intensity and focus: indicators of process for outcomes studies.
Grobe SJ; Hughes LC; Robinson L; Adler DC; Nuamah I; McCorkle R
Stud Health Technol Inform; 1997; 46():8-14. PubMed ID: 10175459
[TBL] [Abstract][Full Text] [Related]
38. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
Bacon CG; Giovannucci E; Testa M; Kawachi I
J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
[TBL] [Abstract][Full Text] [Related]
39. Quality of life in prostate cancer.
Talcott JA; Clark JA
Eur J Cancer; 2005 Apr; 41(6):922-31. PubMed ID: 15808958
[TBL] [Abstract][Full Text] [Related]
40. Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
Brundage M; Osoba D; Bezjak A; Tu D; Palmer M; Pater J;
J Clin Oncol; 2007 Nov; 25(32):5078-81. PubMed ID: 17991924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
